Screenshot 2020-08-02 at 4.23.09 PM
Wednesday, May 13, 2026
33.1
C
Bengaluru
Hot topics
Pharma Marketer and Split Personality
The life of the Pharma marketer has always been a juggling act (Two hands, Three balls, Endless Effect! A Lifetime of Performance) of managing multiple aspects with adept emotional and mental skill sets. All this, while trying to remain sane in a dynamic and confusing world. As the marketer takes time to make sense of his environment, he attempts to find answers to perennial marketing questions such as:
How is the campaign performing?
What are the new avenues to target customers?
Is the messaging, right?
Are the vendors on track with their deliverables?
Are metrics that we track insightful?
Analysis of the Fastest Growing Companies and Therapy Areas in IPM – MAT Dec’24
Growth Performance of Top 50 Companies in IPM (MAT...
Novo Nordisk’s Big Reset: What 9,000 Job Cuts Signal for Pharma’s Future
For years, Novo Nordisk was the poster child of growth. Its GLP-1 drugs, Ozempic and Wegovy, didn’t just change obesity treatment — they reshaped the company’s balance sheet. Demand outpaced supply, public awareness skyrocketed, and Novo’s market cap surged.
But growth always attracts challengers. Enter Eli Lilly with Mounjaro and Zepbound, and a wave of competitors and compounded generics threatening margins. Add in slowing sales growth and operational bloat from years of expansion, and suddenly Novo’s leadership had to answer tough questions about sustainability.
Top 10 Indian Pharma – 2025
India's top 10 pharma companies by market capitalization, offering insights into...
Healthcare’s New Anti‑Fraud Playbook Will Reshape Hospitals, Pharma, Devices and Diagnostics
India’s AI‑enabled, anti‑FWA, interoperable roadmap is not a “payer‑only”...
Do Retail Pharmacies Really Care about Patients?
The chemist shop—jammed between a chai stall and a...
Indian Oncology: An Unasked Question, the Challenges Ahead
A Brief History of Scale and an Unasked Question
In...
Are Quick Remedies Keeping Patients Away from Doctors?
The recent Mint Lounge analysis captured a striking consumer...
From Tragedy to Trust: What the CDCSO Can Learn from Dr. Frances Oldham Kelsey
Abstract
The U.S. Food and Drug Administration (FDA) evolved from...
Biocon’s Landmark Succession Planning: Claire Mazumdar is the Future Leader
In a landmark decision for India’s biotechnology sector, Kiran...
Do Retail Pharmacies Really Care about Patients?
The chemist shop—jammed between a chai stall and a...
Indian Oncology: An Unasked Question, the Challenges Ahead
A Brief History of Scale and an Unasked Question
In...
Are Quick Remedies Keeping Patients Away from Doctors?
The recent Mint Lounge analysis captured a striking consumer...
From Tragedy to Trust: What the CDCSO Can Learn from Dr. Frances Oldham Kelsey
Abstract
The U.S. Food and Drug Administration (FDA) evolved from...
Biocon’s Landmark Succession Planning: Claire Mazumdar is the Future Leader
In a landmark decision for India’s biotechnology sector, Kiran...
Do Retail Pharmacies Really Care about Patients?
The chemist shop—jammed between a chai stall and a...
Indian Oncology: An Unasked Question, the Challenges Ahead
A Brief History of Scale and an Unasked Question
In...
Are Quick Remedies Keeping Patients Away from Doctors?
The recent Mint Lounge analysis captured a striking consumer...
From Tragedy to Trust: What the CDCSO Can Learn from Dr. Frances Oldham Kelsey
Abstract
The U.S. Food and Drug Administration (FDA) evolved from...
Biocon’s Landmark Succession Planning: Claire Mazumdar is the Future Leader
In a landmark decision for India’s biotechnology sector, Kiran...
Do Retail Pharmacies Really Care about Patients?
The chemist shop—jammed between a chai stall and a...
Indian Oncology: An Unasked Question, the Challenges Ahead
A Brief History of Scale and an Unasked Question
In...
Are Quick Remedies Keeping Patients Away from Doctors?
The recent Mint Lounge analysis captured a striking consumer...
From Tragedy to Trust: What the CDCSO Can Learn from Dr. Frances Oldham Kelsey
Abstract
The U.S. Food and Drug Administration (FDA) evolved from...
Biocon’s Landmark Succession Planning: Claire Mazumdar is the Future Leader
In a landmark decision for India’s biotechnology sector, Kiran...
Hot topics
Digital Marketing Kick Starter for Pharma Marketers
An interview with Salil Kallianpur - Executive VP at GSK Primary Care on the state of digital in pharma marketing and pointers for digital marketing success.
Why and How Can Pharma Make the Shift from Product Centricity to Customer Centricity?
The customer is the one who buys a product...
Novo Nordisk’s Big Reset: What 9,000 Job Cuts Signal for Pharma’s Future
For years, Novo Nordisk was the poster child of growth. Its GLP-1 drugs, Ozempic and Wegovy, didn’t just change obesity treatment — they reshaped the company’s balance sheet. Demand outpaced supply, public awareness skyrocketed, and Novo’s market cap surged.
But growth always attracts challengers. Enter Eli Lilly with Mounjaro and Zepbound, and a wave of competitors and compounded generics threatening margins. Add in slowing sales growth and operational bloat from years of expansion, and suddenly Novo’s leadership had to answer tough questions about sustainability.
The Rise and Fall of A.H. Robins Company: A Tale of Innovation Marred by One Acquisition
A.H. Robins Company was a formidable name in the...
Do Retail Pharmacies Really Care about Patients?
The chemist shop—jammed between a chai stall and a...
Indian Oncology: An Unasked Question, the Challenges Ahead
A Brief History of Scale and an Unasked Question
In...
Are Quick Remedies Keeping Patients Away from Doctors?
The recent Mint Lounge analysis captured a striking consumer...
From Tragedy to Trust: What the CDCSO Can Learn from Dr. Frances Oldham Kelsey
Abstract
The U.S. Food and Drug Administration (FDA) evolved from...
Biocon’s Landmark Succession Planning: Claire Mazumdar is the Future Leader
In a landmark decision for India’s biotechnology sector, Kiran...
Do Retail Pharmacies Really Care about Patients?
The chemist shop—jammed between a chai stall and a...
Indian Oncology: An Unasked Question, the Challenges Ahead
A Brief History of Scale and an Unasked Question
In...
Are Quick Remedies Keeping Patients Away from Doctors?
The recent Mint Lounge analysis captured a striking consumer...
From Tragedy to Trust: What the CDCSO Can Learn from Dr. Frances Oldham Kelsey
Abstract
The U.S. Food and Drug Administration (FDA) evolved from...
Biocon’s Landmark Succession Planning: Claire Mazumdar is the Future Leader
In a landmark decision for India’s biotechnology sector, Kiran...
Do Retail Pharmacies Really Care about Patients?
The chemist shop—jammed between a chai stall and a...
Indian Oncology: An Unasked Question, the Challenges Ahead
A Brief History of Scale and an Unasked Question
In...
Are Quick Remedies Keeping Patients Away from Doctors?
The recent Mint Lounge analysis captured a striking consumer...
From Tragedy to Trust: What the CDCSO Can Learn from Dr. Frances Oldham Kelsey
Abstract
The U.S. Food and Drug Administration (FDA) evolved from...
Biocon’s Landmark Succession Planning: Claire Mazumdar is the Future Leader
In a landmark decision for India’s biotechnology sector, Kiran...
Do Retail Pharmacies Really Care about Patients?
The chemist shop—jammed between a chai stall and a...
Indian Oncology: An Unasked Question, the Challenges Ahead
A Brief History of Scale and an Unasked Question
In...
Are Quick Remedies Keeping Patients Away from Doctors?
The recent Mint Lounge analysis captured a striking consumer...
From Tragedy to Trust: What the CDCSO Can Learn from Dr. Frances Oldham Kelsey
Abstract
The U.S. Food and Drug Administration (FDA) evolved from...
Biocon’s Landmark Succession Planning: Claire Mazumdar is the Future Leader
In a landmark decision for India’s biotechnology sector, Kiran...
MedicinMan was launched in 2011 as India’s 1st Magazine dedicated to the cause of Field Force Excellence in Pharma and Devices.
Read More
Headlines
Do Retail Pharmacies Really Care about Patients?
The chemist shop—jammed between a chai stall and a...
Indian Oncology: An Unasked Question, the Challenges Ahead
A Brief History of Scale and an Unasked Question
In...
Are Quick Remedies Keeping Patients Away from Doctors?
The recent Mint Lounge analysis captured a striking consumer...
From Tragedy to Trust: What the CDCSO Can Learn from Dr. Frances Oldham Kelsey
Abstract
The U.S. Food and Drug Administration (FDA) evolved from...
Newsletter
Get important news delivered directly to your inbox and stay connected!